Supplementary Table 1 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma

<p>Supplementary Table 1a. Differentially expressed genes between Post-treatment vs Pre-treatment; Supplementary Table 1b. Differentially expressed genes between Responders vs Nonresponders; Supplementary Table 1c. Differentially expressed genes between PFS longer than 6 months vs PFS shorter...

Ful tanımlama

Kaydedildi:

Detaylı Bibliyografya
Yazar:	Tom Wei-Wu Chen (15053003) (author)
Diğer Yazarlar:	Chia-Lang Hsu (11929719) (author), Ruey-Long Hong (15053006) (author), Jen-Chieh Lee (14954275) (author), Koping Chang (15053009) (author), Chih-Wei Yu (15053012) (author), San-Chi Chen (15050106) (author), Jhe-Cyuan Guo (15053015) (author), Mei-Lu Chen (15053018) (author), Meng-Chi Hsu (15053021) (author), Ting-Fang Kung (15053024) (author), Ann-Lii Cheng (15045786) (author), Chueh-Chuan Yen (15053027) (author)
Baskı/Yayın Bilgisi:	2025
Konular:	Cancer Therapeutic Research and Development Clinical Research and Trials Clinical Trial Results Phase II clinical trials Sarcomas Soft-tissue sarcoma Translational Research
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

İlk yorumlayan siz olun!

Supplementary Table 1 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma

Benzer Materyaller